The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation

Background: Idiopathic pulmonary fibrosis (IPF) is a life-limiting lung disease that generally affects people over 60 years old. The main symptoms are shortness of breath and cough, and as the disease progresses there is a considerable impact on day-to-day life. Few treatments are currently availabl...

Full description

Bibliographic Details
Main Authors: Emma Loveman, Vicky R Copley, Jill Colquitt, David A Scott, Andy Clegg, Jeremy Jones, Katherine MA O’Reilly, Sally Singh, Claudia Bausewein, Athol Wells
Format: Article
Language:English
Published: NIHR Journals Library 2015-03-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta19200